This publication from OmicEra Diagnostics, describes alterations of the serum proteome during COVID-19 using a scalable plasma proteome profiling workflow. It comprises the most detailed longitudinal protein trajectories during hospitalization, based on one of the...
This publication from the Yates lab, investigates the host interactome determining whether a SARS-CoV-2 infection is productive. They find an “S2 only” dependent, alternative infection of additional cell types with SARS-CoV-2 may impact vaccination strategies and...
Clinical data of patients suffering from COVID-19 have indicated that statin therapy, used to treat high cholesterol, is associated with a better clinical outcome. A collaboration led by Gisa Gerold investigated the effect of statins on SARS-CoV-2 infection in human...
In this study, researchers from University of Colorado led by Joaquin M. Espinosa, found highly variable seroconversion status among hospitalized Covid-19 patients. Their results support the existence of distinct pathophysiological states, with seroconversion status...
In this study, researchers from University of Colorado led by Angelo D’Alessandro, performed proteomics analysis of Covid-19 patients and healthy control individuals. They measured the proteomes of red blood cells (RBC) and identified increased glycolysis in RBCs from...
Fill in your information to watch the recorded version of our webinar where you will learn how the pioneering Whisper™ flow technology is driving new Evosep One applications. When you register for the recording you will also join our monthly newsletter. You can unsubscribe at any time.
In this webinar, we will introduce our next addition to our dynamic environment of specialized applications, EVOSEP+. We are developing a set of nanoflow methods for standard Evosep One hardware, which builds on a robust platform allowing for several thousand uninterrupted injections at very low flow rates. We will demonstrate the expected increase in sensitivity and benchmark the performance directly against our established standard methods.
Thank you joining us on October 14th. When you register for you webinar you will also join our monthly newsletter. You can unsubscribe at any time.
Thank you for showing interest. When you have typed in your email, we will receive your request and get back to you shortly.
Thank you for showing interest. When you have typed in your email, we will receive your request and get back to you shortly.
Thank you for showing interest. When you have typed in your email, we will receive your request and get back to you shortly.
Thank you for showing interest. When you have typed in your email, we will receive your request and get back to you shortly.
No Fields Found.
Thank you for showing interest. When you have typed in your email, we will receive your request and get back to you shortly.
Thank you for showing interest. When you have typed in your email, we will receive your request and get back to you shortly.
Thank you for showing interest. When you have successfully typed in your email, a link will be sent to your where you can access the different material you showed interest in.
